May 18, 2026 — AstraZeneca’s Baxfendy (baxdrostat) has been approved in the U.S. as a first-in-class aldosterone synthase inhibitor (ASI) for treating hypertension in combination with other ...
FDA
May 18, 2026 — AstraZeneca’s Baxfendy (baxdrostat) has been approved in the U.S. as a first-in-class aldosterone ...
May 1, 2026 — Philips has received FDA 510(k) clearance for its Smart Fit TorsoCardiac 1.5T coil, a lightweight and ...
April 29, 2026 — Agitated Solutions, Inc.(ASI) has received CE Mark approval in the European Union for its novel device ...
April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...
April 22, 2026 — Stereotaxis recently announced the first patients in the United States have been successfully treated ...
April 20, 2026 — Conavi Medical Corp. recently announced that it has received U.S. Food and Drug Administration (FDA) ...
April 16, 2026 — The U.S. Food and Drug Administration has granted 510(k) clearance to Royal Philips for its Philips ...
April 17, 2026 — Corify Care has announced that the U.S. Food and Drug Administration (FDA) has granted clearance for ...
April 15, 2026 – AliveCor has received CE Mark (Conformité Européenne) for the Kardia 12L electrocardiogram (ECG) System ...
April 7, 2026 —TRiCares SAS has received approval from the U.S. Food and Drug Administration (FDA) for an ...
April 8, 2026 — Anumana, Inc. recently announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI ...
March 31, 2026 — Solo Pace Inc. has announced the commercial release of the SoloPace Fusion Temporary Pacing System. The ...
March 24, 2026 — Anumana has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary ...
March 25, 2026 — Royal Philips has received U.S. Food and Drug Administration (FDA) 510(k) clearance for EchoNavigator ...
March 25, 2026 — Royal Philips has launched its intuitive interventional guidance platform, IntraSight Plus, which is ...
May 18, 2026